Lorenz Hofbauer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Proell Verena; Xu Huiqing; Schüler Christiane; Weber Karin; Hofbauer Lorenz C; Erben Reinhold G
Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.
Hofbauer Lorenz C; Rauner Martina
Minireview: live and let die: molecular effects of glucocorticoids on bone cells.
Goettsch Claudia; Goettsch Winfried; Arsov Alexander; Hofbauer Lorenz C; Bornstein Stefan R; Morawietz Henning
Long-term cyclic strain downregulates endothelial Nox4.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Lorenz Hofbauer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Proell Verena; Xu Huiqing; Schüler Christiane; Weber Karin; Hofbauer Lorenz C; Erben Reinhold G
Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.
Bone 2009;45(4):677-81.
2009: Hofbauer Lorenz C; Rauner Martina
Minireview: live and let die: molecular effects of glucocorticoids on bone cells.
Molecular endocrinology (Baltimore, Md.) 2009;23(10):1525-31.
2009: Goettsch Claudia; Goettsch Winfried; Arsov Alexander; Hofbauer Lorenz C; Bornstein Stefan R; Morawietz Henning
Long-term cyclic strain downregulates endothelial Nox4.
Antioxidants & redox signaling 2009;11(10):2385-97.
2009: Rachner Tilman D; Benad Peggy; Rauner Martina; Goettsch Claudia; Singh Shiv K; Schoppet Michael; Hofbauer Lorenz C
Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.
Journal of cellular biochemistry 2009;108(1):106-16.
2009: Krüger Antonio; Hamann Christine; Brendel Cornelia; Ramaswamy Annette; Schnabel Michael; Neubauer Andreas; Hofbauer Lorenz C
Multimodal therapy for vertebral involvement of systemic mastocytosis.
Spine 2009;34(17):E626-8.
2009: Helas Susann; Goettsch Claudia; Schoppet Michael; Zeitz Ute; Hempel Ute; Morawietz Henning; Kostenuik Paul J; Erben Reinhold G; Hofbauer Lorenz C
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.
The American journal of pathology 2009;175(2):473-8.
2009: Hofbauer Lorenz C; Zeitz Ute; Schoppet Michael; Skalicky Monika; Schüler Christiane; Stolina Marina; Kostenuik Paul J; Erben Reinhold G
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.
Arthritis and rheumatism 2009;60(5):1427-37.
2009: Hofbauer Lorenz C; Miehlke Stephan
More on reports of esophageal cancer with oral bisphosphonate use.
The New England journal of medicine 2009;360(17):1790; author reply 1791-2.
2008: Shroff Rukshana C; Shah Vanita; Hiorns Melanie P; Schoppet Michael; Hofbauer Lorenz C; Hawa Gerhard; Schurgers Leon J; Singhal Atul; Merryweather Ian; Brogan Paul; Shanahan Catherine; Deanfield John; Rees Lesley
The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(10):3263-71.
2008: Stein Nicola C; Kreutzmann Carmen; Zimmermann Sara-Pia; Niebergall Ute; Hellmeyer Lars; Goettsch Claudia; Schoppet Michael; Hofbauer Lorenz C
Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(5):750-8.
2008: Rachner Tilman D; Schoppet Michael; Niebergall Ute; Hofbauer Lorenz C
17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
Biochemical and biophysical research communications 2008;368(3):736-41.
2008: Hofbauer Lorenz C; Rachner Tilman; Singh Shiv K
Fatal attraction: why breast cancer cells home to bone.
Breast cancer research : BCR 2008;10(1):101.
2007: Hofbauer Lorenz C; Khosla Sundeep; Schoppet Michael
Estrogen therapy and coronary-artery calcification.
The New England journal of medicine 2007;357(12):1253-4; author reply 1254.
2007: Hofbauer Lorenz C; Brueck Carolin C; Singh Shiv K; Dobnig Harald
Osteoporosis in patients with diabetes mellitus.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(9):1317-28.
2007: Schrader J; Rennekamp W; Niebergall U; Schoppet M; Jahr H; Brendel M D; Hörsch D; Hofbauer L C
Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death.
Diabetologia 2007;50(6):1243-7.
2007: Jacobs Johannes W G; de Nijs Ron N J; Lems Willem F; Geusens Piet P M M; Laan Roland F J; Huisman Anne-Margriet; Algra Ale; Buskens Erik; Hofbauer Lorenz C; Oostveen Ans C M; Bruyn George A W; Dijkmans Ben A C; Bijlsma Johannes W J
Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
The Journal of rheumatology 2007;34(5):1051-7.
2007: Hoffmann S; Burchert A; Wunderlich A; Wang Y; Lingelbach S; Hofbauer L C; Rothmund M; Zielke A
Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines.
Endocrine 2007;31(2):105-13.
2007: Schoppet Michael; Henser Stephanie; Ruppert Volker; Stübig Thomas; Al-Fakhri Nadia; Maisch Bernhard; Hofbauer Lorenz C
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent.
Journal of cellular biochemistry 2007;100(6):1430-9.
2007: Hofbauer L C; Brueck C C; Shanahan C M; Schoppet M; Dobnig H
Vascular calcification and osteoporosis--from clinical observation towards molecular understanding.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(3):251-9.
2007: Hoffmann Sebastian; Rockenstein Andreas; Ramaswamy Anette; Celik Ilhan; Wunderlich Anette; Lingelbach Susanne; Hofbauer Lorenz C; Zielke Andreas
Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Molecular and cellular endocrinology 2007;264(1-2):74-81.
2006: Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer L C; Zielke A
Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
Endocrine 2006;30(1):129-38.
2006: Hoffmann Sebastian; Wunderlich Anette; Celik Ilhan; Maschuw Katja; Hassan Iyad; Hofbauer Lorenz C; Zielke Andreas
Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.
Journal of cellular biochemistry 2006;98(4):954-65.
2006: Hofbauer L C
Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG).
Annales d'endocrinologie 2006;67(2):139-41.
2006: Hofbauer Lorenz C; Schrader Jörg; Niebergall Ute; Viereck Volker; Burchert Andreas; Hörsch Dieter; Preissner Klaus T; Schoppet Michael
Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells.
Thrombosis and haemostasis 2006;95(4):708-14.
2006: Schoppet Michael; Sattler Alexander M; Schaefer Juergen R; Hofbauer Lorenz C
Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis.
Atherosclerosis 2006;184(2):446-7.
2005: Al-Fakhri Nadia; Hofbauer Lorenz C; Preissner Klaus T; Franke Folker E; Schoppet Michael
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification.
Thrombosis and haemostasis 2005;94(6):1335-7.
2005: Schoppet Michael; Ruppert Volker; Hofbauer Lorenz C; Henser Stephanie; Al-Fakhri Nadia; Christ Michael; Pankuweit Sabine; Maisch Bernhard
TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy.
Biochemical and biophysical research communications 2005;338(4):1745-50.
2005: Heider Ulrike; Hofbauer Lorenz C; Zavrski Ivana; Kaiser Martin; Jakob Christian; Sezer Orhan
Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease.
Biochemical and biophysical research communications 2005;338(2):687-93.
2005: Viereck Volker; Gründker Carsten; Blaschke Sabine; Frosch Karl-Heinz; Schoppet Michael; Emons Günter; Hofbauer Lorenz C
Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Journal of cellular biochemistry 2005;96(6):1244-53.
2005: Viereck Volker; Gründker Carsten; Friess Stephanie C; Frosch Karl-Heinz; Raddatz Dirk; Schoppet Michael; Nisslein Thomas; Emons Günter; Hofbauer Lorenz C
Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(11):2036-43.
2005: Zojer Niklas; Brenner Karin; Beke Dora; Kudlacek Stefan; Hawa Gerhard; Woloszczuk Wolfgang; Hofbauer Lorenz C; Pecherstorfer Martin
Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients.
Anticancer research 2005;25(5):3607-12.
2005: Hammer Fabian; Kenn Werner; Wesselmann Ulrich; Hofbauer Lorenz C; Delling Günter; Allolio Bruno; Arlt Wiebke
Gorham-Stout disease--stabilization during bisphosphonate treatment.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(2):350-3.
2004: Hoffmann Sebastian; Hofbauer Lorenz C; Scharrenbach Vera; Wunderlich Anette; Hassan Iyad; Lingelbach Susanne; Zielke Andreas
Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
The Journal of clinical endocrinology and metabolism 2004;89(12):6139-45.
2004: Franck Helmut; Meurer Thomas; Hofbauer Lorenz Christian
Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.
The Journal of rheumatology 2004;31(11):2236-41.
2004: Hofbauer L C; Kühne C A; Viereck V
The OPG/RANKL/RANK system in metabolic bone diseases.
Journal of musculoskeletal & neuronal interactions 2004;4(3):268-75.
2004: Schoppet Michael; Al-Fakhri Nadia; Franke Folker E; Katz Norbert; Barth Peter J; Maisch Bernhard; Preissner Klaus T; Hofbauer Lorenz C
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
The Journal of clinical endocrinology and metabolism 2004;89(8):4104-12.
2004: Soufi Muhidien; Schoppet Michael; Sattler Alexander M; Herzum Matthias; Maisch Bernhard; Hofbauer Lorenz C; Schaefer Juergen R
Osteoprotegerin gene polymorphisms in men with coronary artery disease.
The Journal of clinical endocrinology and metabolism 2004;89(8):3764-8.
2004: Heider Ulrike; Zavrski Ivana; Jakob Christian; Bängeroth Katharina; Fleissner Claudia; Langelotz Corinna; Possinger Kurt; Hofbauer Lorenz C; Viereck Volker; Sezer Orhan
Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells.
Journal of cancer research and clinical oncology 2004;130(8):469-74.
2004: Hofbauer Lorenz C; Schoppet Michael
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.
JAMA : the journal of the American Medical Association 2004;292(4):490-5.
2004: Hofbauer Lorenz C; Cepok Sabine; Hemmer Bernhard
Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid.
Acta neuropathologica 2004;107(6):575-7, author reply 578.
2004: Burchert Andreas; Cai Dali; Hofbauer Lorenz C; Samuelsson Magnus K R; Slater Emily P; Duyster Justus; Ritter Markus; Hochhaus Andreas; Müller Rolf; Eilers Martin; Schmidt Manuel; Neubauer Andreas
Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
Blood 2004;103(9):3480-9.
2004: Hofbauer Lorenz C; Neubauer Andreas; Schoppet Michael
DKK1 in multiple myeloma.
The New England journal of medicine 2004;350(14):1464-6; author reply 1464-6.
2004: Hofbauer Lorenz C; Schoppet Michael; Schüller Per; Viereck Volker; Christ Michael
Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women.
Clinical endocrinology 2004;60(2):214-9.
2004: Sattler A M; Schoppet M; Schaefer J R; Hofbauer L C
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease.
Calcified tissue international 2004;74(1):103-6.
2003: von Tirpitz Christian; Epp Sonja; Klaus Jochen; Mason Richard; Hawa Gerhard; Brinskelle-Schmal Natascha; Hofbauer Lorenz C; Adler Guido; Kratzer Wolfgang; Reinshagen Max
Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease.
European journal of gastroenterology & hepatology 2003;15(11):1165-70.
2003: Viereck Volker; Gründker Carsten; Blaschke Sabine; Niederkleine Britta; Siggelkow Heide; Frosch Karl-Heinz; Raddatz Dirk; Emons Günter; Hofbauer Lorenz C
Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.
The Journal of clinical endocrinology and metabolism 2003;88(9):4206-13.
2003: Heider Ulrike; Langelotz Corinna; Jakob Christian; Zavrski Ivana; Fleissner Claudia; Eucker Jan; Possinger Kurt; Hofbauer Lorenz C; Sezer Orhan
Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1436-40.
2003: Schoppet Michael; Schaefer Juergen R; Hofbauer Lorenz C
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men.
Circulation 2003;107(11):e76; author reply e76.
2003: von Tirpitz C; Klaus J; Steinkamp M; Hofbauer L C; Kratzer W; Mason R; Boehm B O; Adler G; Reinshagen M
Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.
Alimentary pharmacology & therapeutics 2003;17(6):807-16.
2003: Schoppet Michael; Sattler Alexander M; Schaefer Juergen R; Herzum Matthias; Maisch Bernhard; Hofbauer Lorenz C
Increased osteoprotegerin serum levels in men with coronary artery disease.
The Journal of clinical endocrinology and metabolism 2003;88(3):1024-8.
2003: Sezer Orhan; Heider Ulrike; Zavrski Ivana; Kühne Christian Alexander; Hofbauer Lorenz Christian
RANK ligand and osteoprotegerin in myeloma bone disease.
Blood 2003;101(6):2094-8.
2003: Erben Reinhold G; Brunner Katrin S; Breig Bianca; Eberle Johannes; Goldberg Michel; Hofbauer Lorenz C
Skeletal effects of cyclosporin A are gender related in rats.
Endocrinology 2003;144(1):40-9.
2002: Zielke Andreas; Middeke Martin; Hoffmann Sebastian; Colombo-Benkmann Mario; Barth Peter; Hassan Iyad; Wunderlich Annette; Hofbauer Lorenz C; Duh Quan-Yang
VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Surgery 2002;132(6):1056-63; discussion 1063.
2002: Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer L C; Zielke A
In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2002;110(8):386-92.
2002: Hofbauer Lorenz C; Schoppet Michael
Osteoprotegerin deficiency and juvenile Paget's disease.
The New England journal of medicine 2002;347(20):1622-3; author reply 1622-3.
2002: Hofbauer Lorenz C; Maisch Bernhard; Schaefer Juergen R
High bone density due to a mutation in LDL-receptor-related protein 5.
The New England journal of medicine 2002;347(12):943-4; author reply 943-4.
2002: Hofbauer Lorenz C; Schoppet Michael
Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease.
The Journal of clinical endocrinology and metabolism 2002;87(9):4078-9.
2002: Hofbauer Lorenz C; Allolio Bruno; Arlt Wiebke
Dehydroepiandrosterone supplementation in elderly men: the role of estrogens versus androgens on the male skeleton.
The Journal of clinical endocrinology and metabolism 2002;87(8):4009; author reply 4009.
2002: Hofbauer Lorenz C; Hicok Kevin C; Chen David; Khosla Sundeep
Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells.
European journal of endocrinology / European Federation of Endocrine Societies 2002;147(2):269-73.
2002: Schoppet Michael; Preissner Klaus T; Hofbauer Lorenz C
RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(4):549-53.
2002: Viereck Volker; Emons Günter; Lauck Vanessa; Frosch Karl-Heinz; Blaschke Sabine; Gründker Carsten; Hofbauer Lorenz C
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Biochemical and biophysical research communications 2002;291(3):680-6.
2002: Hofbauer Lorenz C; Kühne Christian A
Cytokine inhibition: a new therapeutic avenue for skeletal diseases.
Drug discovery today 2002;7(5):289.
2002: Hofbauer Lorenz C; Kluger Sibylle; Kühne Christian A; Dunstan Colin R; Burchert Andreas; Schoppet Michael; Zielke Andreas; Heufelder Armin E
Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.
Journal of cellular biochemistry 2002;86(4):642-50.
2002: Viereck Volker; Gründker Carsten; Blaschke Sabine; Siggelkow Heide; Emons Günter; Hofbauer Lorenz C
Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.
Journal of cellular biochemistry 2002;84(4):725-35.
2001: Hofbauer L C; Schoppet M
Serum measurement of osteoprotegerin--clinical relevance and potential applications.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(6):681-3.
2001: Hofbauer L C; Neubauer A; Heufelder A E
Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.
Cancer 2001;92(3):460-70.
2001: Burguera B; Hofbauer L C; Thomas T; Gori F; Evans G L; Khosla S; Riggs B L; Turner R T
Leptin reduces ovariectomy-induced bone loss in rats.
Endocrinology 2001;142(8):3546-53.
2001: Hofbauer L C; Schoppet M
Osteoprotegerin: a link between osteoporosis and arterial calcification?
Lancet 2001;358(9278):257-9.
2001: Hofbauer L C; Heufelder A E
Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.
Journal of molecular medicine (Berlin, Germany) 2001;79(5-6):243-53.
2001: Hofbauer L C; Heufelder A E
[Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases]
Deutsche medizinische Wochenschrift (1946) 2001;126(6):145-50.
2001: Hofbauer L C; Heufelder A E
The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis.
Arthritis and rheumatism 2001;44(2):253-9.
2001: Hofbauer L C; Shui C; Riggs B L; Dunstan C R; Spelsberg T C; O'Brien T; Khosla S
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
Biochemical and biophysical research communications 2001;280(1):334-9.
2001: Hofbauer L C; Kühne C A; Nies C; Heufelder A E
Identical twins with hypercalcaemia due to Lowe's syndrome.
Rheumatology (Oxford, England) 2001;40(1):107-8.
2001: Kühne C A; Heufelder A E; Hofbauer L C
Bone and mineral metabolism in human immunodeficiency virus infection.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(1):2-9.
2000: Gori F; Hofbauer L C; Dunstan C R; Spelsberg T C; Khosla S; Riggs B L
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.
Endocrinology 2000;141(12):4768-76.
2000: Hofbauer L C; Heufelder A E
Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.
The Journal of clinical endocrinology and metabolism 2000;85(7):2355-63.
2000: Hofbauer L C; Khosla S; Dunstan C R; Lacey D L; Boyle W J; Riggs B L
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(1):2-12.
1999: Gori F; Hofbauer L C; Conover C A; Khosla S
Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line.
Endocrinology 1999;140(12):5579-86.
1999: Hofbauer L C; Gori F; Riggs B L; Lacey D L; Dunstan C R; Spelsberg T C; Khosla S
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
Endocrinology 1999;140(10):4382-9.
1999: Hofbauer L C; Lacey D L; Dunstan C R; Spelsberg T C; Riggs B L; Khosla S
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.
Bone 1999;25(3):255-9.
1999: Hofbauer L C
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(3):195-210.
1999: Hofbauer L C; Khosla S; Dunstan C R; Lacey D L; Spelsberg T C; Riggs B L
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.
Endocrinology 1999;140(9):4367-70.
1999: Hofbauer L C; Ten R M; Khosla S
The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(8):1330-7.
1999: Hofbauer L C; Heufelder A E
Osteopetrosis in cathepsin K-deficient mice.
European journal of endocrinology / European Federation of Endocrine Societies 1999;140(5):376-7.
1999: Hofbauer L C; Khosla S
Androgen effects on bone metabolism: recent progress and controversies.
European journal of endocrinology / European Federation of Endocrine Societies 1999;140(4):271-86.
1998: Hofbauer L C; Hicok K C; Khosla S
Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
Journal of cellular biochemistry 1998;71(1):96-108.
1998: Hofbauer L C; Dunstan C R; Spelsberg T C; Riggs B L; Khosla S
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.
Biochemical and biophysical research communications 1998;250(3):776-81.
1998: Hofbauer L C; Heufelder A E
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(2):152-4.
1998: Hofbauer L C; Heufelder A E
Vitamin D receptor knock-out mice: the expectational and the exceptional.
European journal of endocrinology / European Federation of Endocrine Societies 1998;138(4):372-3.
1997: Heshmati H M; Hofbauer L C
Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(6):572-8.
1997: Hofbauer L C; Heufelder A E
Osteoprotegerin: a novel local player in bone metabolism.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(4):345-6.
1997: Hofbauer L C; Hicok K C; Schroeder M J; Harris S A; Robinson J A; Khosla S
Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene.
Journal of cellular biochemistry 1997;66(4):542-51.
1996: Hofbauer L C; Heufelder A E
Taking the message to the nucleus: MAD protein as a mediator of bone morphogenetic protein signaling.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):654-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Lorenz Hofbauer

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Living Beings

Concepts & Ideas

Procedures

Phenomena

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Lorenz Hofbauer (preview)

All Publications